NeOnc Technologies Holdings, Inc. (NTHI)
NASDAQ: NTHI · Real-Time Price · USD
4.070
-0.960 (-19.09%)
At close: Sep 8, 2026, 4:00 PM EDT
4.140
+0.070 (1.72%)
After-hours: Sep 8, 2026, 6:14 PM EDT
NeOnc Technologies Holdings Employees
NeOnc Technologies Holdings had 5 employees as of December 31, 2025. The number of employees decreased by 3 or -37.50% compared to the previous year.
Employees
5
Change
-3
Growth
-37.50%
Revenue / Employee
$7,998
Profits / Employee
-$9,440,000
Market Cap
101.17M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 5 | -3 | -37.50% |
| Dec 31, 2023 | 8 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Nautilus Biotechnology | 127 |
| Cibus | 118 |
| enGene Therapeutics | 82 |
| Rani Therapeutics Holdings | 71 |
| Connect Biopharma Holdings | 64 |
| Vivani Medical | 42 |
| Aardvark Therapeutics | 28 |
| TuHURA Biosciences | 22 |
NTHI News
- 9 hours ago - NeOnc' Phase 2 Data Could Put Cancer on the Ropes - GlobeNewsWire
- 11 days ago - NeOnc's Phase 2A Success Could Set the Stage for Something Much Bigger - GlobeNewsWire
- 13 days ago - NeOnc's Clinical Story Is Now the Main Event - GlobeNewsWire
- 21 days ago - NeOnc Technologies- Talk Is Cheap, Insider Buying Isn't - GlobeNewsWire
- 22 days ago - These Nasdaq Stories Are Heating Up - GlobeNewsWire
- 22 days ago - NTHI's Nasdaq Advantage Takes on New Meaning After Its Breakthrough Phase 2a Results - GlobeNewsWire
- 22 days ago - NeOnc says Phase 2a portion of NEO100-01 study met primary endpoint - TheFly
- 25 days ago - NeOnc Technologies Holdings Transcript: AGM 2026 - Transcripts